Barclays’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $50K | Hold |
|
|||||
|
2022
Q4 | $33K | Sell |
|
|||||
|
2022
Q3 | $60K | Sell |
|
|||||
|
2022
Q2 | $103K | Sell |
|
|||||
|
2022
Q1 | $111K | Sell |
|
|||||
|
2021
Q4 | $229K | Buy |
|
|||||
|
2021
Q3 | $281K | Sell |
|
|||||
|
2021
Q2 | $694K | Sell |
|
|||||
|
2021
Q1 | $1.08M | Buy |
|
|||||
|
2020
Q4 | $353K | Sell |
|
|||||
|
2020
Q3 | $304K | Buy |
|
|||||
|
2020
Q2 | $138K | Buy |
|
|||||
|
2020
Q1 | $30K | Sell |
|
|||||
|
2019
Q4 | $169K | Buy |
|
|||||
|
2019
Q3 | $89K | Buy |
|
|||||
|
2019
Q2 | $16K | Sell |
|
|||||
|
2019
Q1 | $40K | Buy |
|